Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2010-05-26
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Target Recruit Count
- 30
- Registration Number
- NCT00209690
- Locations
- 🇯🇵
・ Hokkaido University Hospital (Hokkaido University Graduate School of Medicine / School of Medicine), Sapporo, Hokkaido, Japan
Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Phase 1
Suspended
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2007-11-01
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Target Recruit Count
- 40
- Registration Number
- NCT00209677
- Locations
- 🇯🇵
Hokkaido University Hospital (Hokkaido University Graduate School of Medicine), Sapporo, Hokkaido, Japan
© Copyright 2024. All Rights Reserved by MedPath